A phase II study (TACTI-002) in first-line metastatic non-small cell lung carcinoma investigating eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab: Updated results from a PD-L1 unselected population
dc.contributor.author | Felip, E. | |
dc.contributor.author | Majem, M. | |
dc.contributor.author | Doger, B. | |
dc.contributor.author | Clay, T. D. | |
dc.contributor.author | Carcereny, E. | |
dc.contributor.author | Bondarenko, I. | |
dc.contributor.author | Peguero, J. A. | |
dc.contributor.author | Cobo-Dols, M. | |
dc.contributor.author | Forster, M. | |
dc.contributor.author | Ursol, G. | |
dc.contributor.author | Ledo, G. G. | |
dc.contributor.author | Vila, L. | |
dc.contributor.author | Krebs, Matthew G | |
dc.contributor.author | Iams, W. T. | |
dc.contributor.author | Mueller, C. | |
dc.contributor.author | Triebel, F. | |
dc.date.accessioned | 2022-11-30T10:21:29Z | |
dc.date.available | 2022-11-30T10:21:29Z | |
dc.date.issued | 2022 | en |
dc.identifier.citation | Felip E, Majem M, Doger B, Clay TD, Carcereny E, Bondarenko I, et al. A phase II study (TACTI-002) in first-line metastatic non-small cell lung carcinoma investigating eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab: Updated results from a PD-L1 unselected population. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680302194. | en |
dc.identifier.doi | 10.1200/JCO.2022.40.16_suppl.9003 | en |
dc.identifier.uri | http://hdl.handle.net/10541/625818 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1200/JCO.2022.40.16_suppl.9003 | en |
dc.title | A phase II study (TACTI-002) in first-line metastatic non-small cell lung carcinoma investigating eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab: Updated results from a PD-L1 unselected population | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain; | en |
dc.identifier.journal | Journal of Clinical Oncology | en |
dc.description.note | en] |